Global Clinical Trials | KinderPharm
Conducting clinical trials in children can involve many clinical, scientific technical and logistical challenges. Most, if not all, pediatric conditions can be classified as rare diseases, and drugs developed for pediatric indications usually fall within the definition of an orphan drug. The comparatively low numbers of pediatric patients can pose significant logistical challenges for enrollment. This often necessitates use of multiple trial sites, across wide geographic regions, a feature of pediatric trials that requires careful planning, coordination and management in order to ensure the timely completion of studies and quality data.
Pediatric trials also span most of the major therapeutic areas seen in adults. These include:
- Infectious diseases
- Cardiovascular disease
- Respiratory disease
- Pediatric cancer
- Psychiatric disorders
- Hematologic diseases
- Endocrine/metabolic diseases
- Gastrointestinal conditions
- Renal Disease
There are also a number of specialist areas, unique to pediatrics including:
- Intensive care needs
- Neonatal research
- Adolescent research
Pediatric trials at any stage of development
KinderPharm’s comprehensive range of pediatric drug development capabilities means we can assist clients with their pediatric trials at any stage of development. This includes PIP and PDP design and planning, protocol development, feasibility assessments, study design and assistance with troubleshooting study-related issues based on knowledge and experience of pediatric development.
Global pediatric research network
We have established an extensive global network with leading pediatric clinical sites and centers of excellence in pediatric research. This enables us to quickly engage investigators with the relevant therapeutic area expertise in order to conduct trials to the highest clinical, scientific and ethical standards.
Contact us to discuss your clinical trial, data management and regulatory needs.